Marijuana Stocks Surge as Trump Prepares to Sign Executive Order for Drug Reclassification
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Source: MarketWatch
Cannabis Stock Surge: Cannabis stocks rose on Thursday morning following news that President Trump is expected to sign an executive order to reschedule marijuana.
Rescheduling Marijuana: The proposed change would reclassify marijuana from a Schedule I drug, which includes substances like heroin, to a Schedule III drug, aligning it with some prescription medications.
Market Reaction: The cannabis sector had already seen a surge in stock prices the previous week due to preliminary reports about Trump's intentions regarding marijuana classification.
Implications of Rescheduling: Rescheduling marijuana could have significant implications for its legality, regulation, and market dynamics in the United States.
Analyst Views on MSOS
Wall Street analysts forecast MSOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 4.520
Low
Averages
High
Current: 4.520
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
